Table 1.
Baseline comparison of cardiovascular risk
| Variables | STEP Patients (n=76) |
NHANES Controls (n=156) |
|---|---|---|
| Smokers3 | 32 (42%) | 51 (33%) |
| Body Mass Index (kg/m2)2 | 25.0 (4.0) | 26.1 (5.2) |
| Systolic blood pressure, mm of Hg 1, 2 | 122.5 (10.4) | 115.8 (9.9) |
| Diastolic blood pressure, mm of Hg 1, 2 | 72.3 (10.3) | 66.0 (9.4) |
| Fasting serum glucose2 | 88.8 (7.7) | 91.2 (9.1) |
| NHANES-defined Diabetes3 | 0 (0%) | 1 (0.6%) |
| Impaired fasting glucose (FPG: 100–125 mg /dL)3 | 7 (9%) | 16 (10%) |
| Total Cholesterol, mg /dL2 | 169.8 (25.4) | 171.7 (32.0) |
| HDL Cholesterol, mg /dL2 | 50.9 (10.7) | 51.9 (13.2) |
| LDL Cholesterol, mg /dL2 | 91.8 (10.2) | 96.2 (16.3) |
| Triglyceride, mg /dL2 | 89.5 (16.7) | 92.9 (20.2) |
| HbA1C | 5.46 (0.3) | 5.25 (0.6) |
| Prevalence of Metabolic Syndrome, n(%) | 1 (1.31%) | 2 (1.28%) |
| 10-year risk for developing coronary heart disease, % Mean (SD) Median (Range) |
0.70 (1.02) 0 (0–5) |
0.74 (1.03) 0 (0–5) |
1
p<0.05,
2
mean (SD),
3
n (%)